Discover open access scientific publications

Search, annotate, share and cite publications

Publications by L. Liang

IRS1 Genotype Modulates Metabolic Syndrome Reversion in Response to 2-Year Weight-Loss Diet Intervention: The POUNDS LOST Trial

Diabetes Care

English

CAFs Secreted Exosomes Promote Metastasis and Chemotherapy Resistance by Enhancing Cell Stemness and Epithelial-Mesenchymal Transition in Colorectal Cancer

English

ASC-J9 Suppresses Renal Cell Carcinoma Progression by Targeting an Androgen Receptor-Dependent HIF2 /VEGF Signaling Pathway

Cancer Research

Oncology

2014

English

P2.13-05 Real-World Clinical Benefit of Continuing Crizotinib Beyond Progression Disease (CBPD) in Patients With Advanced ALK-Positive NSCLC.

Journal of Thoracic Oncology

English

P2.13-30 High-Dose Icotinib in Advanced Non-Small Cell Lung Cancer With EGFR 21 L858R Mutation: The Randomized, Open-Label INCREASE Study

Journal of Thoracic Oncology

English

OA13 High-Dose Icotinib in Advanced NSCLC With EGFR 21 L858R Mutation: A Randomized, Open-Label Phase II Study

Journal of Thoracic Oncology

English

P3.01-103 Efficacy of Crizotinib in Chinese Non-Small Cell Lung Cancer Patients With Brain Metastasis: A Multicenter Retrospective Study

Journal of Thoracic Oncology

English

P2.13-04 Outcomes of ALK-Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated With Crizotinib: A Multicenter Cohort Retrospective Study.

Journal of Thoracic Oncology

English

A Genome-Wide Association Study of Cutaneous Squamous Cell Carcinoma Among European Descendants

Cancer Epidemiology Biomarkers and Prevention

English

Emissions of Air-Borne Mercury From Five Municipal Solid Waste Landfills in Guiyang and Wuhan, China

Atmospheric Chemistry and Physics

Atmospheric Science

2010

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by L. Liang

IRS1 Genotype Modulates Metabolic Syndrome Reversion in Response to 2-Year Weight-Loss Diet Intervention: The POUNDS LOST Trial

CAFs Secreted Exosomes Promote Metastasis and Chemotherapy Resistance by Enhancing Cell Stemness and Epithelial-Mesenchymal Transition in Colorectal Cancer

ASC-J9 Suppresses Renal Cell Carcinoma Progression by Targeting an Androgen Receptor-Dependent HIF2 /VEGF Signaling Pathway

P2.13-05 Real-World Clinical Benefit of Continuing Crizotinib Beyond Progression Disease (CBPD) in Patients With Advanced ALK-Positive NSCLC.

P2.13-30 High-Dose Icotinib in Advanced Non-Small Cell Lung Cancer With EGFR 21 L858R Mutation: The Randomized, Open-Label INCREASE Study

OA13 High-Dose Icotinib in Advanced NSCLC With EGFR 21 L858R Mutation: A Randomized, Open-Label Phase II Study

P3.01-103 Efficacy of Crizotinib in Chinese Non-Small Cell Lung Cancer Patients With Brain Metastasis: A Multicenter Retrospective Study

P2.13-04 Outcomes of ALK-Positive Non-Small-Cell Lung Cancer (NSCLC) Patients Treated With Crizotinib: A Multicenter Cohort Retrospective Study.

A Genome-Wide Association Study of Cutaneous Squamous Cell Carcinoma Among European Descendants

Emissions of Air-Borne Mercury From Five Municipal Solid Waste Landfills in Guiyang and Wuhan, China